Sponsor study identifier
Secondary identifiers
NIH
observational
60
1 country
1
Study Start
September 16, 2019
Actual (reported)Primary Completion
September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The study will consist of two parts:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 16, 2019
Actual (reported)April 29, 2020
Actual (reported)May 11, 2020
Actual (reported)September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Difference in gait symmetry
The subjects will perform an instrumented gait analysis on an overground walkway with two embedded force plates
approximate duration: 30 minutes. Assessment will be performed at visit 1 and will be repeated 6 months after study inclusion at visit 2
Change in balance performance
Balance performance will be assessed using the modified clinical test of sensory integration of balance (m-CTSIB) using the Biodex Balance System SD
approximate duration: 30 minutes. Assessment will be performed at visit 1 and will be repeated 6 months after study inclusion at visit 2.
Difference in neurophysiological outcome
Quantitative score of Motor evoked potentials (MEP) and Somato-sensory evoked potentials (SEP)
approximate duration: 30 minutes. Assessment will be performed at visit 1 and will be repeated 6 months after study inclusion at visit 2.
Difference in daily physical activity
monitored for 7 consecutive days at visit 1 or 1 week before surgery and 6 months later at visit 2
Difference in spinal cord gray and white matter areas
approximate duration of the scan: 30. Assessment will be performed at visit 1 and will be repeated 6 months after study inclusion at visit 2 (Measurement at visit 2 only in patients with cervical spine stenosis treated conservatively).
Change in segmental quantitative muscle strength
approximate duration: 10 minutes. Assessment will be performed at visit 1 and will be repeated 6 months after study inclusion at visit 2.
Change in 25-foot walk test
approximate duration: 3 minutes. Assessment will be performed at visit 1 and will be repeated 6 months after study inclusion at visit 2.
Change in 6-minute walk test
approximate duration: 6 minutes. Assessment will be performed at visit 1 and will be repeated 6 months after study inclusion at visit 2.
In study A this group will be treated conservatively (stenosis). Study B is a single centre longitudinal study where the same patient groups will be followed up during the course of their treatment
In study A this group that will be treated surgically (stenosis and myelopathy). Study B is a single centre longitudinal study where the same patient groups will be followed up during the course of their treatment
conservative treatment for patients with cervical spine stenosis without myelopathy
surgical decompress the spinal canal in patients with moderate to severe degenerative cervical spine myelopathy
Patients with degenerative cervical spine stenosis with or without myelopathy.
Universitätsspital Basel
Basel, 4031, Switzerland
Annegret Mündermann, Prof. Dr.
University Hospital, Basel, Switzerland
Cordula Netzer, Dr. med.
University Hospital, Basel, Switzerland
Regina Schläger, PD Dr. med.
University Hospital, Basel, Switzerland
Martin Hardmeier, PD Dr. med.
University Hospital, Basel, Switzerland
First Submitted
April 29, 2020
First Posted
May 11, 2020
Study Start
September 16, 2019
Actual (reported)Primary Completion
September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Activity Monitors as a Measure of Physical Function in Degenerative Cervical Myelopathy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Study Completion
September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
December 9, 2024
Record last verified: 2024-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: